Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patrones de cambio de los inhibidores de la tirosina cinasa BCR-ABL1 en pacientes con LMC en fase crónica en la práctica clínica rutinaria estudio simplicity
    Meeting Abstract

    Encinas, M. P.; Goldberg, S. L.; Michallet, M.; Hehlmann, R.; Zyczynski, T.; Foreman, A.; Calimlim, B.; Paquette, R.; Simonsson, B.; Gambacorti Passerini, C.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Bosutinib (BOS) Vs Imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE Trial
    Meeting Abstract

    Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; Hochhaus, A.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Symptom burden, palliative care needs, and patient-provider communication among chronic myeloid leukemia survivors
    Meeting Abstract

    Zaleta, A. K.; Miller, M. F.; Johnson, J.; McManus, S.; Karten, C.; Mauro, M. J.; Buzaglo, J. S.
    Blood (2017)

    Fulltext@MSK | Save
  • Single-arm salvage therapy with pegylated interferon alfa-2a for patients with high-risk polycythemia vera or high-risk essential thrombocythemia who are either hydroxyurea-resistant or intolerant: Final results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 global phase II trial
    Meeting Abstract

    Yacoub, A.; Mascarenhas, J.; Kosiorek, H. E.; Prchal, J. T.; Berenzon, D.; Baer, M. R.; Ritchie, E. K.; Silver, R. T.; Kessler, C. M.; Winton, E. F.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Graft-vs-leukemia effect in acute lymphoblastic leukemia: Mild acute graft-vs-host disease protects against relapse and improves survival after allogeneic transplantation: A CIBMTR analysis
    Meeting Abstract

    Yeshurun, M.; Weisdorf, D. J.; Zhang, M. J.; Wang, H. L.; Flowers, M. E.; De Lima, M.; Rowe, J. M.; Sandmaier, B. M.; Tallman, M. S.; Verneris, M. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Spliceosomal dysfunction Is a critical mediator of IDH2 mutant leukemogenesis
    Meeting Abstract

    Yoshimi, A.; Lin, K. T.; Wiseman, D.; Intlekofer, A. M.; Wang, B.; Pastore, A.; Rahman, M.; Lee, S. C. W.; Liu, B.; Micol, J. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Association between Nuclear SET domain (NSD) Protein Lysine Methyltransferases (KMT) expression and poor prognosis in acute promyelocytic leukemia (APL) patients treated with ATRA and anthracycline protocol
    Meeting Abstract

    Wagatsuma, V. M. D. D.; Pereira-Martins, D. A.; Mendoza, S. E. S.; Koury, L. C. A.; Nascimento, M. C.; Melo, R. A. M.; Bittencourt, R.; Pagnano, K. B.; Pasquini, R.; Chiattone, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Low relapse rate in younger patients ≤ 60 years old with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) treated with crenolanib and cytarabine/anthracycline chemotherapy
    Meeting Abstract

    Wang, E. S.; Tallman, M. S.; Stone, R. M.; Walter, R. B.; Karanes, C.; Jain, V.; Collins, R. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Myeloproliferative neoplasm (MPN) blastic transformation occurs at the level of both short and long term hematopoietic stem cells
    Meeting Abstract

    Wang, X.; Hu, C. S.; Rampal, R. K.; Tripodi, J.; Najfeld, V.; Petersen, B.; Mascarenhas, J.; Hoffman, R.
    Blood (2017)

    Fulltext@MSK | Save
  • PHF6 mutations defines a subgroup of mixed phenotype of acute leukemia with aberrant T-cell differentiation
    Meeting Abstract

    Xiao, W.; Pastore, F.; Getta, B.; Hultquist, A.; Shaffer, B. C.; Giralt, S. A.; Rampal, R. K.; Arcila, M. E.; Levine, R. L.; Roshal, M.
    Blood (2017)

    Fulltext@MSK | Save